Immediate Impact

68 standout
Sub-graph 1 of 23

Citing Papers

Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
2023 Standout
Switching to once-weekly insulin icodec versus once-daily insulin glargine U100 in individuals with basal-bolus insulin-treated type 2 diabetes (ONWARDS 4): a phase 3a, randomised, open-label, multicentre, treat-to-target, non-inferiority trial
2023 Standout
1 intermediate paper

Works of Jeffrey Schaider being referenced

Safe and Simple Emergency Department Discharge Therapy for Patients with Type 2 Diabetes Mellitus and Severe Hyperglycemia
2009

Author Peers

Author Last Decade Papers Cites
Jeffrey Schaider 115 50 50 23 338
Dennis G. Cochrane 96 31 46 30 376
Ayfer Keleş 90 24 62 39 323
Michael P Pietrzak 112 77 91 18 379
Robert G. Scherz 87 29 57 31 405
Jonathan D. Auten 144 34 68 38 381
Melanie Hogg 35 76 75 19 363
Scott R Votey 146 69 69 18 368
Laura Pimentel 108 36 50 31 368
Shabana Yusuf 101 15 42 19 362
G Heller 63 66 108 33 387

All Works

Loading papers...

Rankless by CCL
2026